Market revenue in 2023 | USD 330.9 million |
Market revenue in 2030 | USD 375.1 million |
Growth rate | 1.8% (CAGR from 2023 to 2030) |
Largest segment | Fresh nondonor |
Fastest growing segment | Frozen Nondonor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Fresh nondonor was the largest segment with a revenue share of 46.96% in 2023. Horizon Databook has segmented the Canada in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
There has been a growing demand for IVF services in Canada, driven by factors such as delayed childbearing, increasing awareness & acceptance of fertility treatments, and advancements in technology. This has led to an expansion of IVF clinics across the country.
Furthermore, the COVID-19 pandemic had a significant negative impact on various markets, including the fertility services market in Canada. The pandemic resulted in disruptions and challenges that affected the demand for & provision of fertility treatments.
For instance, according to a report released by Statistics Canada in December 2021, the COVID-19 pandemic prompted a significant shift in the reproductive intentions of many Canadians aged 15 to 49. The report indicates that individuals in this age group have experienced a change of heart concerning their plans for having children due to the impact of the pandemic.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into Canada in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account